CLINICAL_TRIALS
withdrawal
· 2015-03-25
Clinical Trial Update: Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function [Phase 4]
Summary
A Phase 4 trial comparing chlorthalidone versus hydrochlorothiazide for endothelial function in hypertension has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Creighton University | Conditions: Hypertension | Phase 4 | Status: WITHDRAWN